Sleemon Healthy Sleep Technology Co., Ltd. (SHA:603008)
China · Delayed Price · Currency is CNY 10.32
-0.54 (-4.97%)
Apr 30, 2026, 3:00 PM CST
SHA:603008 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 8,819 | 8,594 | 8,579 | 7,741 | 7,652 |
Other Revenue | - | 135.04 | 99.67 | 97.35 | 119.39 |
| 8,819 | 8,729 | 8,678 | 7,839 | 7,772 | |
Revenue Growth (YoY) | 1.03% | 0.58% | 10.71% | 0.86% | 38.21% |
Cost of Revenue | 5,662 | 5,803 | 5,713 | 5,317 | 5,295 |
Gross Profit | 3,156 | 2,926 | 2,966 | 2,522 | 2,477 |
Selling, General & Admin | 2,442 | 2,323 | 2,171 | 1,919 | 1,498 |
Research & Development | 198.97 | 162.16 | 179.85 | 191.49 | 183.22 |
Other Operating Expenses | 47.21 | 48.03 | 51.99 | 58.74 | 52.42 |
Operating Expenses | 2,689 | 2,555 | 2,454 | 2,187 | 1,787 |
Operating Income | 467.69 | 371.77 | 511.71 | 334.4 | 689.37 |
Interest Expense | - | -78 | -70.23 | -89.96 | -65.99 |
Interest & Investment Income | - | 29.69 | 43.93 | 36.42 | 74.18 |
Currency Exchange Gain (Loss) | - | 27.65 | 33.79 | 28.91 | -12.37 |
Other Non Operating Income (Expenses) | -82.97 | -9.17 | -5.21 | -6.62 | -4.81 |
EBT Excluding Unusual Items | 384.72 | 341.94 | 513.98 | 303.16 | 680.39 |
Gain (Loss) on Sale of Investments | -14.66 | 8.21 | -1.2 | -22.36 | 1.34 |
Gain (Loss) on Sale of Assets | -0.01 | 0.12 | -1.45 | -2.36 | -4.29 |
Asset Writedown | -51.41 | -23.72 | -1.34 | - | 0 |
Other Unusual Items | - | 27.84 | 45.43 | 43.82 | 29.8 |
Pretax Income | 318.64 | 354.4 | 555.41 | 322.26 | 707.25 |
Income Tax Expense | 80.75 | 27.83 | 107.64 | 50.04 | 101.92 |
Earnings From Continuing Operations | 237.89 | 326.57 | 447.77 | 272.22 | 605.33 |
Minority Interest in Earnings | 3.52 | -4.21 | -18.9 | -34.67 | -46.58 |
Net Income | 241.41 | 322.36 | 428.87 | 237.55 | 558.75 |
Net Income to Common | 241.41 | 322.36 | 428.87 | 237.55 | 558.75 |
Net Income Growth | -25.11% | -24.83% | 80.54% | -57.49% | 78.29% |
Shares Outstanding (Basic) | 371 | 379 | 386 | 383 | 385 |
Shares Outstanding (Diluted) | 371 | 379 | 386 | 383 | 385 |
Shares Change (YoY) | -2.07% | -1.84% | 0.84% | -0.57% | -1.64% |
EPS (Basic) | 0.65 | 0.85 | 1.11 | 0.62 | 1.45 |
EPS (Diluted) | 0.65 | 0.85 | 1.11 | 0.62 | 1.45 |
EPS Growth | -23.53% | -23.42% | 79.03% | -57.24% | 81.25% |
Free Cash Flow | 249.91 | 425.19 | 680.4 | -13.25 | 211.54 |
Free Cash Flow Per Share | 0.67 | 1.12 | 1.76 | -0.04 | 0.55 |
Dividend Per Share | - | 0.520 | 0.500 | 0.080 | 0.280 |
Dividend Growth | - | 4.00% | 525.00% | -71.43% | 12.00% |
Gross Margin | 35.79% | 33.53% | 34.17% | 32.17% | 31.87% |
Operating Margin | 5.30% | 4.26% | 5.90% | 4.27% | 8.87% |
Profit Margin | 2.74% | 3.69% | 4.94% | 3.03% | 7.19% |
Free Cash Flow Margin | 2.83% | 4.87% | 7.84% | -0.17% | 2.72% |
EBITDA | 720.69 | 534.67 | 762.74 | 484.45 | 824.98 |
EBITDA Margin | 8.17% | 6.13% | 8.79% | 6.18% | 10.62% |
D&A For EBITDA | 253 | 162.89 | 251.03 | 150.05 | 135.6 |
EBIT | 467.69 | 371.77 | 511.71 | 334.4 | 689.37 |
EBIT Margin | 5.30% | 4.26% | 5.90% | 4.27% | 8.87% |
Effective Tax Rate | 25.34% | 7.85% | 19.38% | 15.53% | 14.41% |
Revenue as Reported | - | 8,729 | 8,678 | 7,839 | 7,772 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.